CompoAtlas

LIFT.C+

Food supplement declared in France, declaration No 2018-12-251

LIFT.C+ is a food supplement declared in France. Status: retiré du marché le 1 December 2024. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
NUTRAVITAL
Status
Retiré du marché le 1 December 2024
Form
Gélule
Daily dose
UNE GELULE PAR JOUR
Directions for use
PRENDRE UNE GELULE PAR JOUR A CONSOMMER DE PREFERENCE LE MATIN A JEUN AVEC UN GRAND VERRE D EAU.
Intended populations
Homme, Femme
Objectives stated by the manufacturer (these are not authorised claims)
Antioxydant, Peau

Declaration 292433, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Other active ingredients

NamePer day
Céramidesnot declared
Collagène marinnot declared
Bêta-alaninenot declared
Ubiquinonenot declared

Additives

E470b, E551

Other ingredients

maltodextrine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

En lien avec l'application du règlement INCO, l'étiqutage fait apparaître en gras les allergènes présents dans ce produit : poissons et sulfites par le collagène marin, blé par les céramides. Le fournisseur des céramides garantit toutefois que le produit fini puisse être étiqueté sans gluten.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line